National Comprehensive Cancer Network® (NCCN®) is pleased to announce a collaboration with Pfizer Global Medical Grants (GMGP) to offer a new grant opportunity to support Quality Improvement projects that will advance health care quality, the delivery of quality care, and improve health care provider performance in metastatic prostate cancer (mPCa) care.
The intent of the RFP is to encourage NCCN Member and non-NCCN Member Institutions in the United States to submit proposals describing the development of innovative, impactful, scalable, and sustainable quality improvement projects that will advance the delivery of quality mPCa care.
To be considered for funding, full proposals must be submitted through the Pfizer portal by 5:00 pm ET on Wednesday, July 1, 2026. Please direct questions regarding this RFP to Nicole Zion at zion@nccn.org and Lori Carpenter at lori.carpenter@pfizer.com with the subject line, “NCCN Pfizer mPCa RFP.”